Samrat Pharmachem Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 797.45 million compared to INR 711.17 million a year ago. Revenue was INR 800.44 million compared to INR 712.56 million a year ago. Net loss was INR 1.88 million compared to net income of INR 59.13 million a year ago. Basic loss per share from continuing operations was INR 0.61 compared to basic earnings per share from continuing operations of INR 19.14 a year ago.
For the six months, sales was INR 1,372.25 million compared to INR 1,576.18 million a year ago. Revenue was INR 1,378.89 million compared to INR 1,577.88 million a year ago. Net income was INR 4.23 million compared to INR 152.79 million a year ago. Basic earnings per share from continuing operations was INR 1.37 compared to INR 49.45 a year ago.